130 related articles for article (PubMed ID: 31575798)
1. Electro Cell Fusion for Hybridoma Production.
Greenfield EA
Cold Spring Harb Protoc; 2019 Oct; 2019(10):. PubMed ID: 31575798
[TBL] [Abstract][Full Text] [Related]
2. On chip electrofusion of single human B cells and mouse myeloma cells for efficient hybridoma generation.
Kemna EW; Wolbers F; Vermes I; van den Berg A
Electrophoresis; 2011 Nov; 32(22):3138-46. PubMed ID: 22025094
[TBL] [Abstract][Full Text] [Related]
3. Polyethylene Glycol Fusion for Hybridoma Production.
Greenfield EA
Cold Spring Harb Protoc; 2018 Mar; 2018(3):. PubMed ID: 29496822
[TBL] [Abstract][Full Text] [Related]
4. Cell activation by CpG ODN leads to improved electrofusion in hybridoma production.
Kato M; Sasamori E; Chiba T; Hanyu Y
J Immunol Methods; 2011 Oct; 373(1-2):102-10. PubMed ID: 21878337
[TBL] [Abstract][Full Text] [Related]
5. Increased human hybridoma formation by electrofusion of human B cells with heteromyeloma SPAM-8 cells.
Panova I; Gustafsson B
Hybridoma; 1995 Jun; 14(3):265-9. PubMed ID: 7590790
[TBL] [Abstract][Full Text] [Related]
6. Efficient generation of stable antibody forming hybridoma cells by electrofusion.
Schmitt JJ; Zimmermann U; Neil GA
Hybridoma; 1989 Feb; 8(1):107-15. PubMed ID: 2925206
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of hybridoma secreting anti-mycobacteria monoclonal antibody by using electrofusion technique].
Guo M; Pan Z; Wang H
Wei Sheng Wu Xue Bao; 1998 Oct; 38(5):393-5. PubMed ID: 12549406
[TBL] [Abstract][Full Text] [Related]
8. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
Glaser RW; Jahn S; Grunow R
Allerg Immunol (Leipz); 1989; 35(2):123-32. PubMed ID: 2788981
[TBL] [Abstract][Full Text] [Related]
9. Selective production of hybridoma cells: antigenic-based pre-selection of B lymphocytes for electrofusion with myeloma cells.
Tomita M; Tsong TY
Biochim Biophys Acta; 1990 Dec; 1055(3):199-206. PubMed ID: 2265207
[TBL] [Abstract][Full Text] [Related]
10. Hybridoma technologies for antibody production.
Tomita M; Tsumoto K
Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
[TBL] [Abstract][Full Text] [Related]
11. Electrofusion by a bipolar pulsed electric field: Increased cell fusion efficiency for monoclonal antibody production.
Ke Q; Li C; Wu M; Ge L; Yao C; Yao C; Mi Y
Bioelectrochemistry; 2019 Jun; 127():171-179. PubMed ID: 30831355
[TBL] [Abstract][Full Text] [Related]
12. Highly controlled electrofusion of individually selected cells in dielectrophoretic field cages.
Kirschbaum M; Guernth-Marschner CR; Cherré S; de Pablo Peña A; Jaeger MS; Kroczek RA; Schnelle T; Mueller T; Duschl C
Lab Chip; 2012 Feb; 12(3):443-50. PubMed ID: 22124613
[TBL] [Abstract][Full Text] [Related]
13. Optimization of bulk cell electrofusion in vitro for production of human-mouse heterohybridoma cells.
Trontelj K; Rebersek M; Kanduser M; Serbec VC; Sprohar M; Miklavcic D
Bioelectrochemistry; 2008 Nov; 74(1):124-9. PubMed ID: 18667367
[TBL] [Abstract][Full Text] [Related]
14. Enhanced hybridoma production by electrofusion in strongly hypo-osmolar solutions.
Schmitt JJ; Zimmermann U
Biochim Biophys Acta; 1989 Jul; 983(1):42-50. PubMed ID: 2758049
[TBL] [Abstract][Full Text] [Related]
15. Electrofusion of single cells in picoliter droplets.
Schoeman RM; van den Beld WTE; Kemna EWM; Wolbers F; Eijkel JCT; van den Berg A
Sci Rep; 2018 Feb; 8(1):3714. PubMed ID: 29487332
[TBL] [Abstract][Full Text] [Related]
16. Electrofusion between heterogeneous-sized mammalian cells in a pellet: potential applications in drug delivery and hybridoma formation.
Li LH; Hensen ML; Zhao YL; Hui SW
Biophys J; 1996 Jul; 71(1):479-86. PubMed ID: 8804630
[TBL] [Abstract][Full Text] [Related]
17. Cell electrofusion using nanosecond electric pulses.
Rems L; Ušaj M; Kandušer M; Reberšek M; Miklavčič D; Pucihar G
Sci Rep; 2013 Nov; 3():3382. PubMed ID: 24287643
[TBL] [Abstract][Full Text] [Related]
18. Microscale production of hybridomas by hypo-osmolar electrofusion.
Zimmermann U; Klöck G; Gessner P; Sammons DW; Neil GA
Hum Antibodies Hybridomas; 1992 Jan; 3(1):14-8. PubMed ID: 1576318
[TBL] [Abstract][Full Text] [Related]
19. Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity.
Tomita M; Fukuda T; Ozu A; Kimura K; Tsong TY; Yoshimura T
Hybridoma (Larchmt); 2006 Oct; 25(5):283-92. PubMed ID: 17044784
[TBL] [Abstract][Full Text] [Related]
20. A microfluidic approach towards hybridoma generation for cancer immunotherapy.
Lu YT; Pendharkar GP; Lu CH; Chang CM; Liu CH
Oncotarget; 2015 Nov; 6(36):38764-76. PubMed ID: 26462149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
